Abstract:Aging is known to contribute to the development of endothelial dysfunction and as such facilitates the development of cardiovascular diseases (CVD). The loss of the ability of endothelial cells to produce physiological amounts of nitric oxide (NO) partly underlies the detrimental effects of aging. Thus, the identification of agents that can mitigate aging induces loss of endothelial cell function (i.e. NO production) are of great interest. Several reports indicate that the administration of the cacao flavanol (−)‐epicatechin (Epi), can partly reverse the deleterious effects of aging in organs such as the heart and kidneys. However, less is known on its effect on aged endothelium. To address this question, we implemented a primary cell model of aging that is based on the use of high passage number (31–35) bovine coronary endothelial cells (BCAEC) in culture. We specifically evaluated NO production through the endothelial NO synthase (NOS) pathway, markers of cell senescence (β‐galactosidase) and mitochondrial biogenesis (sirtuin‐1, mitofilin, oxidative phosphorylation complexes II, IV and V, Tfam and citrate synthase activity). BCAEC at low passage number (8–13 passage number) were used as “young” controls. Cells were treated with either vehicle (water) of Epi (100 nM) for 48 h and media and cells collected for testing using kits (NO, citrate synthase) or Western blots. All experiments were performed independently a minimum of 3 times in triplicate. All results were statistically analyzed. Results indicate that senile cells loose their capacity to produce NO by ~33% (p<0.05) and that Epi treatment can essentially fully restore their production levels to those noted for vehicle treated young cells. These results paralleled to those noted for the phosphorylation of eNOS. While β‐galactosidase levels doubled (100% increase) in aged cells, those treated with Epi only evidenced about a 40% increase (p<0.05). The levels of phosphorylated sirtuin‐1, mitofilin, oxidative phosphorylation complexes and Tfam were all reduced by ~40% with aging (p<0.05) and were largely restored by Epi treatment. Altogether, results strongly suggest that Epi can partly reverse markers of endothelial cell aging by restoring critical components of vascular function. These effects may partly explain the epidemiological evidence for the beneficial effects of cocoa consumption on the incidence of CVD. Support or Funding Information NIH DK98717

Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells

Therapeutic potential of nitric oxide in vascular aging due to the promotion of angiogenesis

Replicative Endothelial Cell Senescence May Lead to Endothelial Dysfunction by Increasing the BH2/BH4 Ratio Induced by Oxidative Stress, Reducing BH4 Availability, and Decreasing the Expression of eNOS

Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells

Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence

Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells

Estrogen-SIRT1 Axis Plays a Pivotal Role in Protecting Arteries Against Menopause-Induced Senescence and Atherosclerosis

Heme oxygenase-1 ameliorates oxidative stress-induced endothelial senescence via regulating endothelial nitric oxide synthase activation and coupling

Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1

Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging

Beneficial Effects of (−)‐Epicatechin on Biomarkers of Endothelial Cell Aging

Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging

Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments

GW24-e3737 MicroRNA-210 mediates the protective effect of nitrate on endothelial progenitor cells against senescence induced by angiotensin II through suppressing gene SCH9

Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms.

Sodium Tanshinone IIA Sulfonate alleviates vascular senescence in diabetic mice by modulating the A20-NFκB-NLRP3 inflammasome-catalase pathway

Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway

Oxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells

Nitric oxide delays oocyte aging